Pasithea Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KTTA and other ETFs, options, and stocks.About KTTA
Pasithea Therapeutics Corp. is a biotechnology company focused on the research and discovery of new and treatments for psychiatric and neurological disorders. The company was founded by Yassine Bendiabdallah and Lawrence J.
CEOTiago Reis Marques
CEOTiago Reis Marques
Employees4
Employees4
HeadquartersMiami Beach, Florida
HeadquartersMiami Beach, Florida
Founded2020
Founded2020
Employees4
Employees4
KTTA Key Statistics
Market cap26.32M
Market cap26.32M
Price-Earnings ratio-0.23
Price-Earnings ratio-0.23
Dividend yield—
Dividend yield—
Average volume42.63M
Average volume42.63M
High today$1.21
High today$1.21
Low today$1.10
Low today$1.10
Open price$1.15
Open price$1.15
Volume1.46M
Volume1.46M
52 Week high$3.85
52 Week high$3.85
52 Week low$0.281
52 Week low$0.281
Stock Snapshot
The current Pasithea Therapeutics(KTTA) stock price is $1.14, with a market capitalization of 26.32M. The stock trades at a price-to-earnings (P/E) ratio of -0.23.
During the trading session on 2025-12-04, Pasithea Therapeutics(KTTA) shares reached a daily high of $1.21 and a low of $1.10. At a current price of $1.14, the stock is +3.7% higher than the low and still -5.6% under the high.
Trading activity shows a volume of 1.46M, compared to an average daily volume of 42.63M.
Over the past 52 weeks, Pasithea Therapeutics(KTTA) stock has traded between a high of $3.85 and a low of $0.28.
Over the past 52 weeks, Pasithea Therapeutics(KTTA) stock has traded between a high of $3.85 and a low of $0.28.
People also own
Based on the portfolios of people who own KTTA. This list is generated using Robinhood data, and it’s not a recommendation.